2023-25022. Proposed Collection; 60-Day Comment Request; Cancer Therapy Evaluation Program (CTEP) Branch and Support Contracts Forms and Surveys (NCI)  

  • Start Preamble

    AGENCY:

    National Institutes of Health, HHS.

    ACTION:

    Notice.

    SUMMARY:

    In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.

    DATES:

    Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Michael Montello, Cancer Therapy Evaluation Program—DCTD, National Cancer Institute, 9609 Medical Center Drive, Rockville, Maryland 20850 or call non-toll-free number (240) 276–6080 or email your request, including your address to: montellom@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology.

    Proposed Collection Title: Cancer Therapy Evaluation Program (CTEP) Branch and Support Contracts Forms and Surveys (NCI), 0925–0753, Expiration Date 03/31/2026, REVISION, National Cancer Institute (NCI), National Institutes of Health (NIH).

    Need and Use of Information Collection: This is a request for OMB to approve the revised information collection, Cancer Therapy Evaluation Program (CTEP) Support Contracts Forms and Survey. It includes modifications to OMB-approved forms for the CTSU and CIRB and the addition of new forms for the CTSU, CIRB, and CTEP. The National Cancer Institute (NCI) CTEP and the Division of Cancer Prevention (DCP) fund an extensive national program of cancer research, sponsoring clinical trials in cancer prevention, symptom management, and treatment for qualified clinical investigators. As part of this effort, CTEP implements programs to register clinical site investigators and clinical site staff and to oversee the conduct of research at the clinical sites. CTEP and DCP also oversee two support programs, the NCI Central Institutional Review Board (CIRB) and the Cancer Trial Support Unit (CTSU). The combined systems and processes for initiating and managing clinical trials are termed the Clinical Oncology Research Enterprise (CORE) and represent an integrated set of information systems and processes that support investigator registration, trial oversight, patient enrollment, and clinical data collection. The information collected is required to ensure compliance with applicable federal regulations governing the conduct of human subjects' research (45 CFR 46 and 21 CRF 50), and when CTEP acts as the Investigational New Drug (IND) holder (Food and Drug Administration (FDA) regulations pertaining to the sponsor of clinical trials and the selection of qualified investigators under 21 CRF 312.53). Survey collections assess satisfaction and provide feedback to guide improvements with processes and technology.

    OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 162,831 hours.

    Estimated Annualized Burden Hours

    Form nameType of respondentNumber of respondentsNumber of responses per respondentAverage burden per response (in hours)Total annual burden hours
    CTSU IRB/Regulatory Approval Transmittal Form (Attachment A01)Health Care Practitioner2444122/60978
    CTSU IRB Certification Form (Attachment A02)Health Care Practitioner24441210/604888
    Start Printed Page 78054
    Withdrawal from Protocol Participation Form (Attachment A03)Health Care Practitioner279110/6047
    Site Addition Form (Attachment A04)Health Care Practitioner801210/60160
    CTSU Request for Clinical Brochure (Attachment A06)Health Care Practitioner360110/6060
    CTSU Supply Request Form (Attachment A07)Health Care Practitioner901210/60180
    RTOG 0834 CTSU Data Transmittal Form (Attachment A10)Health Care Practitioner3025/605
    CTSU Patient Enrollment Transmittal Form (Attachment A15)Health Care Practitioner121210/6024
    CTSU Transfer Form (Attachment A16)Health Care Practitioner360210/60120
    CTSU OPEN Rave Request Form (Attachment A18)Health Care Practitioner302110/60105
    CTSU LPO Form Creation (Attachment A19)Health Care Practitioner52120/6020
    CTSU Site Form Creation and PDF (Attachment A20)Health Care Practitioner4001030/602000
    CTSU PDF Signature Form (Attachment A21)Health Care Practitioner4001010/60667
    CTSU CLASS Course Setup Request Form (Attachment A22)Health Care Practitioner10220/607
    CTSU LPO Approval of Early Closure Form (Attachment A23)Health Care Practitioner2444620/604888
    International DTL Signing (Attachment 24)Health Care Practitioner29110/605
    NCI CIRB AA & DOR between the NCI CIRB and Signatory Institution (Attachment B01)Participants50115/6013
    NCI CIRB Signatory Enrollment Form (Attachment B02)Participants50115/6013
    CIRB Board Member Application (Attachment B03)Board Member100130/6050
    CIRB Member COI Screening Worksheet (Attachment B08)Board Members100115/6025
    CIRB COI Screening for CIRB meetings (Attachment B09)Board Members72115/6018
    CIRB IR Application (Attachment B10)Health Care Practitioner80160/6080
    CIRB IR Application for Exempt Studies (Attachment B11)Health Care Practitioner4130/602
    CIRB Amendment Review Application (Attachment B12)Health Care Practitioner400115/60100
    CIRB Ancillary Studies Application (Attachment B13)Health Care Practitioner1160/601
    CIRB Continuing Review Application (Attachment B14)Health Care Practitioner400115/60100
    Adult IR of Cooperative Group Protocol (Attachment B15)Board Members651180/60195
    Pediatric IR of Cooperative Group Protocol (Attachment B16)Board Members151180/6045
    Adult Continuing Review of Cooperative Group Protocol (Attachment B17) ProtocolBoard Members275160/60275
    Adult Amendment of Cooperative Group Protocol (Attachment B19)Board Members401120/6080
    Pediatric Amendment of Cooperative Group Protocol (Attachment B20)Board Members251120/6050
    Pharmacist's Review of a Cooperative Group Study (Attachment B21)Board Members501120/60100
    Adult Expedited Amendment Review (Attachment B23)Board Members348130/60174
    Pediatric Expedited Amendment Review (Attachment B24)Board Members140130/6070
    Adult Expedited Continuing Review (Attachment B25)Board Members140130/6070
    Pediatric Expedited Continuing Review (Attachment B26)Board Members36130/6018
    Adult Cooperative Group Response to CIRB Review (Attachment B27)Health Care Practitioner30160/6030
    Pediatric Cooperative Group Response to CIRB Review (Attachment B28)Health Care Practitioner5160/605
    Adult Expedited Study Chair Response to Required Modifications (Attachment B29)Board Members40130/6020
    Reviewer Worksheet—Determination of UP or SCN (Attachment B31)Board Members400110/6067
    Start Printed Page 78055
    Reviewer Worksheet—CIRB Statistical Reviewer Form (Attachment B32)Board Members100115/6025
    CIRB Application for Translated Documents (Attachment B33)Health Care Practitioner100130/6050
    Reviewer Worksheet of Translated Documents (Attachment B34)Board Members100115/6025
    Reviewer Worksheet of Recruitment Material (Attachment B35)Board Members20115/605
    Reviewer Worksheet Expedited Study Closure Review (Attachment B36)Board Members20115/605
    Reviewer Worksheet of Expedited IR (Attachment B38)Board Members5130/603
    Annual Signatory Institution Worksheet About Local Context (Attachment B40)Health Care Practitioner400140/60267
    Annual Principal Investigator Worksheet About Local Context (Attachment B41)Health Care Practitioner1800120/60600
    Study-Specific Worksheet About Local Context (Attachment B42)Health Care Practitioner4800115/601200
    Study Closure or Transfer of Study Review Responsibility (Attachment B43)Health Care Practitioner1680115/60420
    Unanticipated Problem or Serious or Continuing Noncompliance Reporting Form (Attachment B44)Health Care Practitioner360120/60120
    Change of Signatory Institution PI Form (Attachment B45)Health Care Practitioner120120/6040
    Request Waiver of Assent Form (Attachment B46)Health Care Practitioner35120/6012
    CIRB Waiver of Consent Request Supplemental Form (Attachment B47)Health Care Practitioner20115/605
    Review Worksheet CIRB Review for Inclusion of Incarcerated Participants (Attachment B48)Board Members20160/6020
    Notification of Incarcerated Participant Form (Attachment B49)Health Care Practitioner20120/607
    Final Video Submission Posting Form (Attachment B50)Health Care Practitioner80115/6020
    Unanticipated Problem or Serious or Continuing Noncompliance Application (Attachment B52)Health Care Practitioner20130/6010
    CIRB Customer Satisfaction Survey (Attachment C04)Participants600115/60150
    Follow-up Survey (Communication Audit) (Attachment C05)Participants/ Board Members300115/6075
    CIRB Board Member Annual Assessment Survey (Attachment C07)Board Members60115/6015
    Audit Scheduling Form (Attachment D01)Health Care Practitioner229521/60401
    Preliminary Audit Finding Form (Attachment D02)Health Care Practitioner229510/60191
    Audit Maintenance Form (Attachment D03)Health Care Practitioner15859/60119
    Final Audit finding Report Form (Attachment D04)Health Care Practitioner110111098/6022143
    Follow-up Form (Attachment D05)Health Care Practitioner44727/60139
    Roster Maintenance Form (Attachment D06)Health Care Practitioner7118/602
    Final Report and CAPA Request Form (Attachment D07)Health Care Practitioner391800/60810
    NCI/DCTD/CTEP FDA Form 1572 for Annual Submission (Attachment E01)Physician26,500115/606625
    NCI/DCTD/CTE Biosketch (Attachment E02)Physician; Health Care Practioner48,0001120/6096000
    NCI/DCTD/CTEP Financial Disclosure Form (Attachment E03)Physician; Health Care Practioner48,000115/6012000
    NCI/DCTD/CTEP Agent Shipment Form (ASF) (Attachment E04)Physician24,000110/604000
    NINT Registration Form?Health Care Practitioner, Other1,000160/601000
    ISS FormPhysician2,100115/60525
    Basic Study Information Form (Attachment TBD)Health Care Practioner140120/6047
    Totals173,463253,510162,831
    Start Signature
    Start Printed Page 78056

    Dated: November 8, 2023.

    Diane Kreinbrink,

    Project Clearance Liaison, National Cancer Institute, National Institutes of Health.

    End Signature End Supplemental Information

    [FR Doc. 2023–25022 Filed 11–13–23; 8:45 am]

    BILLING CODE 4140–01–P

Document Information

Published:
11/14/2023
Department:
National Institutes of Health
Entry Type:
Notice
Action:
Notice.
Document Number:
2023-25022
Dates:
Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
Pages:
78053-78056 (4 pages)
PDF File:
2023-25022.pdf